Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose paclitaxel and cisplatin for metastatic breast cancer
NCT00270569Phase 2Unknown
- Sponsor
- Far Eastern Memorial Hospital
- Start
- Oct 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of paclitaxel and cisplatin in breast cancer, sponsored by Far Eastern Memorial Hospital. Primary endpoint: Objective Response Rate at 8 weeks. Status: unknown.
02
Drugs
paclitaxelcisplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00270569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00270569.